Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01301248
What this trial is testing

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsAJCC Stage III/IV
Theagenio Cancer Hospital 80
Early research (Phase 1)Study completedNCT01716416
What this trial is testing

Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Washington University School of Medicine 32
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Not applicableWithdrawnNCT06603155
What this trial is testing

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic Head-and-neck Squamous-cell CarcinomaUnresectable Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Duke University
Not applicableEnded earlyNCT01891695
What this trial is testing

OPSCC N0 Nodal Control With Reduced IMRT

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)HPV (Human Papillomavirus)-Associated
Paul W. Read, MD 1
Testing effectiveness (Phase 2)Looking for participantsNCT06978829
What this trial is testing

Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC

Who this might be right for
LA HNSCC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 42
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Early research (Phase 1)Looking for participantsNCT03114462
What this trial is testing

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Who this might be right for
Malignant Neoplasms of Respiratory and Intrathoracic OrgansSquamous Cell Carcinoma of the Larynx
M.D. Anderson Cancer Center 11
Early research (Phase 1)Ended earlyNCT00443261
What this trial is testing

Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma
University of Kansas Medical Center 1
Early research (Phase 1)Study completedNCT00049166
What this trial is testing

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer

Who this might be right for
Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)UnknownNCT02976051
What this trial is testing

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Who this might be right for
Locally Advanced Head and Neck CancerRadiotherapyHypoxic Radioresistance
Danish Head and Neck Cancer Group 60
Testing effectiveness (Phase 2)Study completedNCT00671437
What this trial is testing

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell
Washington University School of Medicine 42
Testing effectiveness (Phase 2)Study completedNCT02268695
What this trial is testing

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 541
Not applicableUnknownNCT04117139
What this trial is testing

The Diagnostic Value of PET/MRI in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsLymph Node Metastases
Odense University Hospital 142
Not applicableEnded earlyNCT01303237
What this trial is testing

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHN
Merck KGaA, Darmstadt, Germany 88
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Testing effectiveness (Phase 2)Study completedNCT04326257
What this trial is testing

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dan Zandberg 20
Testing effectiveness (Phase 2)Looking for participantsNCT06572514
What this trial is testing

De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ruijin Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05964101
What this trial is testing

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

Who this might be right for
NeoplasmsCarcinoma, SquamousAntineoplastic Agents
The First Affiliated Hospital of Guangzhou Medical University 25
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Next Page